| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C0036043> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C0524785> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C0679809> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C0687742> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C0814767> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C2936405> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C3661486> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32681537_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.\', \'School of Medicine, University of Liverpool, Liverpool, UK.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Alfirevic_Ana> <https://research.tib.eu/covid-19/entity/Back_David> <https://research.tib.eu/covid-19/entity/Beoku-Betts_Christopher> <https://research.tib.eu/covid-19/entity/Chadwick_Amy_E> <https://research.tib.eu/covid-19/entity/Goldring_Christopher_E> <https://research.tib.eu/covid-19/entity/Jensen_Rebecca_L> <https://research.tib.eu/covid-19/entity/Khoo_Saye_H> <https://research.tib.eu/covid-19/entity/Kiy_Robyn_T> <https://research.tib.eu/covid-19/entity/Meng_Xiaoli> <https://research.tib.eu/covid-19/entity/Owen_Andrew> <https://research.tib.eu/covid-19/entity/Park_B_Kevin> <https://research.tib.eu/covid-19/entity/Penman_Sophie_L> <https://research.tib.eu/covid-19/entity/Pirmohamed_Munir>
?:doi	<https://research.tib.eu/covid-19/entity/10.1111/bph.15204>
?:doi	10.1111/bph.15204
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t> <https://research.tib.eu/covid-19/entity/Review>
?:journal	British journal of pharmacology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32681537>
?:pmid	<https://research.tib.eu/covid-19/entity/32681537>
?:pmid	32681537
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.603
?:rankingScore_hIndex	186
?:title	Safety perspectives on presently considered drugs for the treatment of COVID-19.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32681537>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32681537>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all